INCYTE: EXPECTS TO FILE A SBLA FOR TAFASITAMAB FOR FIRST-LINE TREATMENT OF ADULTS WITH NEWLY DIAGNOSED DLBCL IN H1 2026

Reuters · 5d ago

Please log in to view news